Host-microbiota-environment Interactions
Study of the Determinants of Pediatric Onset Inflammatory Diseases: Host-microbiota-environment Interactions
University Hospital, Clermont-Ferrand
60 participants
Mar 16, 2022
OBSERVATIONAL
Conditions
Summary
Two types of inflammatory and autoimmune diseases (excluding monogenic diseases) can be distinguished in children: those similar to adult diseases but with an early onset (type 1 diabetes, inflammatory diseases of the gastrointestinal tract, rheumatoid arthritis with anti-CCP antibodies) and those specific to children that are not described in adults (early-onset juvenile idiopathic arthritis with anti-nuclear and anterior uveitis). The familial and nosological aggregations suggest that these diseases are probably polygenically determined, and result from interactions with the environment. In a singular way, the incidence of "adult" diseases is increasing while the age of onset is getting earlier; conversely, there is no increase in early-onset juvenile idiopathic arthritis. On the other hand, the influence of early events that may alter the microbiotic environment is different for different diseases: whereas cesarean section (or early antibiotic therapy) has been shown to increase the risk of JIA and T1DM, it does not seem to change the risk of IBD. We hypothesize that environmental factors, particularly those related to diet and bacterial and fungal digestive microbiota - are different between these disease categories.
Eligibility
Inclusion Criteria4
- CASE:
- \- Newly diagnosed with JIA, IBD or T1DM
- CONTROL:
- \- Brother/sister of child with pediatric onset inflammatory disease (same age category - same environment: diet, living environment)
Exclusion Criteria2
- Child with antibiotic treatment in the 4 weeks preceding the stool sample
- Recent digestive infectious disease (bacterial, viral, parasitic) (end of episode < 7 days)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Comparaison of the gut microbiota composition
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05176795